3 Stocks Pushing The Health Services Industry Higher
All three major indices are trading down today with the
Dow Jones Industrial Average
(
^DJI
) trading down 134 points (-0.7%) at 17,815 as of Tuesday, July 5, 2016, 12:55 PM ET. The NYSE advances/declines ratio sits at 682 issues advancing vs. 2,296 declining with 110 unchanged.
The Health Services industry currently sits down 1.4% versus the S&P 500, which is down 0.8%. Top gainers within the industry include
(
), up 1.4%, and
(
), up 1.0%. On the negative front, top decliners within the industry include
(
), down 2.8%,
(
), down 1.0%,
(
), down 0.9%,
(
), down 0.6% and
(
), down 0.6%.
TheStreet would like to highlight 3 stocks pushing the industry higher today:
3.
(
) is one of the companies pushing the Health Services industry higher today. As of noon trading, C.R. Bard is up $2.90 (1.2%) to $237.65 on average volume. Thus far, 194,314 shares of C.R. Bard exchanged hands as compared to its average daily volume of 469,600 shares. The stock has ranged in price between $235.00-$238.23 after having opened the day at $235.05 as compared to the previous trading day's close of $234.75.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
C. R. Bard, Inc., together with its subsidiaries, designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. C.R. Bard has a market cap of $17.2 billion and is part of the health care sector. Shares are up 23.9% year-to-date as of the close of trading on Friday. Currently there are 3 analysts who rate C.R. Bard a buy, no analysts rate it a sell, and 12 rate it a hold.
TheStreet Ratings rates
C.R. Bard
as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and solid stock price performance. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
2. As of noon trading,
(
) is up $1.37 (0.8%) to $171.01 on light volume. Thus far, 335,820 shares of Becton Dickinson exchanged hands as compared to its average daily volume of 947,000 shares. The stock has ranged in price between $169.25-$171.57 after having opened the day at $169.29 as compared to the previous trading day's close of $169.64.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. Becton Dickinson has a market cap of $36.0 billion and is part of the health care sector. Shares are up 10.1% year-to-date as of the close of trading on Friday. Currently there are 9 analysts who rate Becton Dickinson a buy, no analysts rate it a sell, and 5 rate it a hold.
TheStreet Ratings rates
Becton Dickinson
as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, good cash flow from operations, growth in earnings per share and expanding profit margins. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full
Becton Dickinson Ratings Report
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
1. As of noon trading,
(
) is up $0.87 (0.7%) to $121.28 on light volume. Thus far, 443,810 shares of Stryker exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $119.73-$121.34 after having opened the day at $119.73 as compared to the previous trading day's close of $120.41.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Stryker Corporation, together with its subsidiaries, operates as a medical technology company. It operates through three segments: Orthopaedics; MedSurg; and Neurotechnology and Spine. Stryker has a market cap of $45.0 billion and is part of the health care sector. Shares are up 29.6% year-to-date as of the close of trading on Friday. Currently there are 16 analysts who rate Stryker a buy, 2 analysts rate it a sell, and 6 rate it a hold.
TheStreet Ratings rates
Stryker
as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and notable return on equity. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider
Health Care Select Sector SPDR
(
) while those bearish on the health services industry could consider
ProShares Ultra Short Health Care
(
).